Mary Talley Bowden MD

08/31/2025

NEW ARTICLE: 43-Year-Old Idaho Woman with Stage 4 NSCLC Lung Cancer and Thyroid Cancer Reports Remarkable Results After 2 Months Using (iver***tin) and (fen***zole)

Many individuals with advanced lung cancer have been reporting significant responses when adding (iver***tin) and (fen***zole) into their personal protocols. While mainstream oncology continues to rely on chemotherapy and radiation as the primary treatment options, more and more patient stories suggest that these alternative additions may play a critical role in improving outcomes. 😃

Story:

A 43-year-old woman from Idaho was diagnosed with Stage 4 Non-Small Cell Lung Cancer (NSCLC). She also had a history of Thyroid Cancer. With the seriousness of her condition, she and her family decided to explore every possible avenue that could give her a fighting chance.

Her journey began on April 8. Alongside the standard chemotherapy prescribed by her oncologist, she added the following regimen:
• (iver***tin) at ** mg/kg per day
• (fen***zole) at *mg per day
• CBD oil at ** mg per day

Her oncologist initiated chemotherapy around the same time, but no mention was made of these additional substances to the oncology team.

Results After 2 Months:

The primary lingular lung mass, initially measuring 5.3 x 5.6 cm, was reduced to 2.5 x 4.0 cm after just two months. This equates to an impressive 76% tumor volume reduction (as calculated by Grok).

The family expressed amazement at the results, pointing out that such a dramatic reduction in tumor size is almost never seen with chemotherapy alone—something that even some oncologists acknowledge privately. Typically, chemo may slow growth or cause modest shrinkage, but to see over three-quarters of the tumor volume disappear in this timeframe is exceptional.

Discussion:

This case adds to a growing collection of testimonials where patients combine standard treatments with substances like (iver***tin) and (fen*****zole). While it is impossible to say definitively which factor caused the dramatic improvement, the speed and scale of response raise questions worth exploring further.

For patients facing advanced diagnoses, stories like this one provide a sense of hope and reinforce the importance of being proactive in exploring all possible treatment strategies.

Note: this is for educational purposes only and this is not a medical advice.

08/24/2025

Ivermectin Mary bowden

08/24/2025

😯

08/24/2025

🚨BREAKING: Fenbendazole Linked to Remission or Near-Remission in THREE Stage IV Cancer Patients

New study reports breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy 👇

✅Case 1: 83-year-old woman, Stage IV Breast → Complete Remission (3 years)

✅Case 2: 75-year-old man, Stage IV Prostate → Near-Complete Remission (26 months, undetectable PSA)

✅Case 3: 63-year-old man, Stage IV Melanoma → Complete Remission (11 months)

Outcomes mirror preclinical findings on fenbendazole’s anti-cancer activity. Similar to ivermectin, fenbendazole may act as a powerful anticancer agent.

Clinical trials should be urgently initiated to test fenbendazole’s true potential.

08/21/2025

NEW ARTICLE: (Iver****in) & (Mebe***zole) SUCCESS STORY – 45-Year-Old Ontario Woman with High-Grade GLIOMA Shows Remarkable Progress After 4 Months!

CASE SUMMARY:
A 45-year-old woman from Ontario was diagnosed with a high-grade glioma. After undergoing surgery that left behind residual tumor, she began taking (Iver****in) and (Mebe***zole) consistently for four months.

At first, during our initial Zoom consultation, she was very nervous about trying this approach. I took the time to reassure her, carefully walking her through the procedure step by step until she felt confident moving forward.

RESULTS:
Follow-up imaging revealed that the remaining tumor tissue had completely disappeared, with no evidence of new tumor growth. Her doctors now describe her condition as stable.

Her own words:

“The portion of tumor that remained after surgery is gone, and there’s no sign of regrowth anywhere in the brain. I finally feel hopeful again.”

MY REFLECTION:
When it comes to aggressive brain cancers, standard oncology often has very limited long-term solutions. What we are seeing with (Iver*in) and (Mebe***ole) is highly encouraging: not only in preventing recurrence, but also in clearing residual tumor tissue post-surgery.

It’s worth noting that major research centers have filed patents and initiated clinical trials around (Meben***zole) in glioblastoma treatment, so this area is gaining serious attention.

Our clinic works with the largest international base of patients using (Iver****in) in cancer care, and we continue to see inspiring outcomes.

08/21/2025

Look at that list. Now look around you.
Parasites are real and way more common than you think.
🧠🦠

08/19/2025

08/15/2025

NEW ARTICLE:
IVERMECTIN and FENBENDAZOLE Testimonial – 59-Year-Old Liverpool Man with Stage 4 Prostate Cancer Metastatic to Lungs and Spine – PSA Drops from 79 to 0.32 in Just 4 Months

We continue to receive an incredible number of prostate cancer recovery stories, and each one is a reminder of what is possible when we combine powerful, science-backed protocols with determination and hope. 😃

⸻

STORY:
This is the story of a 59-year-old man from Liverpool who was diagnosed with Stage 4 Prostate Cancer that had already spread (metastasized) to both his lungs and spine. His condition was considered advanced and, by conventional medical standards, very difficult to treat with any expectation of long-term survival.

In early February 2025, he began a targeted protocol through our clinic, which included:
• Iverme**in – &@$mg/kg/day
• Fenben&$ole – ** mg/day
• CBD Oil – ** mg/day

These compounds were carefully dosed and monitored as part of a broader supportive program. Each plays a role:
•
• CBD Oil – to support the immune system, manage inflammation, and improve overall well-being.

⸻

Results After 4 Months:
By June 2025, his PSA levels had dropped from a dangerously high 79 to an astonishing 0.32. This type of dramatic improvement is rarely seen in late-stage metastatic prostate cancer using conventional treatments alone.

Even more encouraging, his energy levels improved, pain decreased, and his lung function tests showed better oxygen exchange. His spine pain reduced enough that he could resume light walking exercises daily.

About Our telehealth Clinic:
I run the world’s largest Iver$$ctin telehealth Clinic, and time and again, our patients achieve better results than any cancer center in North America. This is not just about numbers on a chart — our patients:
• Do better clinically (with improved symptoms and daily functioning)
• Have better lab results
• Enjoy better long-term outcomes compared to standard oncology expectations

This is yet another inspiring reminder that hope is never lost, and that even in late-stage cancer, remarkable turnarounds are possible.

For educational purposes

08/07/2025

IVERMECTIN and FENBENDAZOLE TESTIMONIAL
23-Year-Old Edinburgh Woman with Stage 4 Lung Cancer and Thyroid Cancer Shows Astonishing Progress in Just 2 Months

It’s no exaggeration to say that we’re witnessing results that are rewriting what people thought was possible—especially for late-stage cancer. This story comes from Edinburgh, where a 23-year-old woman has seen dramatic improvement in her fight against advanced lung cancer using a protocol centered on Ivermectin and Fenbendazole.

Her Story:

At just 23 years old, this young woman from Edinburgh was given a devastating diagnosis: Stage 4 Non-Small Cell Lung Cancer (NSCLC). Already dealing with a medical history that included thyroid cancer, this second cancer came as a heavy blow to her and her family. Traditional options were offered—chemotherapy, radiation—but the prognosis was grim, and the side effects overwhelming.

That’s when her family began to research other options. They came across testimonies from others around the world who had used Ivermectin and Fenbendazole, two repurposed medications—originally used in veterinary and parasitic treatments—that were gaining attention in alternative cancer treatment circles.

The Treatment Plan:

On April 8, she began the following protocol under close supervision and support:
• Ive&$$$ctin: mg per kg of body weight per day
• Fenben@$zole: ***mg per day
• CBD Oil: 100 mg per day
• Chemotherapy was also started simultaneously by her oncologist, unaware of the complementary protocol.

The aim was to harness the synergistic effect of these compounds, which some early studies and anecdotal reports suggest may interfere with cancer cell metabolism, angiogenesis, and immune evasion.

The Results:

After just two months, the change was undeniable.

Her lingular mass, which had originally measured 5.3 x 5.6 cm, was now reduced to 2.5 x 4.0 cm. That’s an estimated 76% reduction in tumor volume, according to calculations run through Grok’s AI-assisted volumetrics.

This kind of tumor shrinkage is virtually unheard of in such a short time using chemotherapy alone. Even her oncologist, though cautious, reportedly admitted surprise at the rapid progress. But like many patients in similar situations, she hadn’t yet told her medical team about the additional protocol she was following.

A Bigger Picture:

This is not a one-off. Stories like hers are surfacing more frequently—especially among those combining traditional treatments with carefully chosen repurposed medications.

As the director of what has grown into the world’s largest Ivermectin telehealth Clinic, I’ve personally witnessed dozens of similar cases. Patients often come to us after being told there’s nothing more to be done. And time after time, we’re seeing hope where there was none.

And yet, it’s not all success and sunshine. You’d be shocked at the extent to which gatekeepers in the pharmaceutical and regulatory world go to—to suppress access to these treatments. It’s not a conspiracy theory. It’s a reality anyone on the front lines of alternative oncology is aware of.

Final Thoughts:

This 23-year-old woman’s journey is far from over. But in just 8 weeks, she’s seen a level of tumor shrinkage that has not only given her hope—it’s quite possibly extended her life. Her energy has returned, her appetite is back, and her scans are improving.

This testimonial is shared not as medical advice, but as inspiration. For patients, caregivers, and doctors willing to explore the frontiers of cancer therapy, stories like this represent a vital part of the conversation. **For educational purposes

08/05/2025

This is amazing. Facebook should stop censoring things like this.

Ivermectin and Mebendazole Testimonial – 53-Year-Old Man in the USA with Advanced Lung Cancer

A 69-year-old American man with advanced non-small cell lung cancer (NSCLC) that had spread to his lymph nodes, adrenal glands, and brain had been on Keytruda since April 2024. At the end of January 2025, we added:
• Ivermectin at a dose based on body weight (1.5 mg per kg daily)
• Mebe**€zole at **** mg per day

Just over a month later, a follow-up PET scan showed:
• Almost complete disappearance of the previously active cancer in his chest lymph nodes
• The adrenal tumors no longer showed signs of aggressive activity

These changes were seen after starting Ivermectin and Mebendazole.

My Perspective…
I say this to my new patients all the time, not all patients who come to me are worsening. Some are already seeing some benefit from traditional treatments like chemotherapy, radiation, or immunotherapy.

This is where Ivermectin, Mebendazole, and even Fenbendazole can make a huge difference. They don’t just attack cancer cells directly—they also seem to make chemotherapy and radiation more effective by making cancer cells more sensitive to those treatments. for educational purposes.